Challenges to conducting a clinical trial of combination therapy of colistin and rifampicin for extensively drug-resistant Acinetobacter baumannii

Clin Infect Dis. 2014 Jan;58(1):141-2. doi: 10.1093/cid/cit630. Epub 2013 Sep 30.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acinetobacter Infections / drug therapy*
  • Acinetobacter baumannii / drug effects*
  • Anti-Bacterial Agents / therapeutic use*
  • Colistin / therapeutic use*
  • Drug Resistance, Multiple, Bacterial*
  • Female
  • Humans
  • Male
  • Rifampin / therapeutic use*

Substances

  • Anti-Bacterial Agents
  • Rifampin
  • Colistin